Post-Infection Fatigue Syndromes in the Era of Long COVID: The Case of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Nuno Sepúlveda; João Malato; João Carlos Winck; António Vaz Carneiro; Joan Serra Hoffman; Jaime Branco

doi:10.20344/amp.21845

Post-Infection Fatigue Syndromes in the Era of Long COVID: The Case of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Authors

Nuno Sepúlveda Faculty of Mathematics & Information Science. Warsaw University of Technology. Varsóvia; Centro de Estatística e Aplicações (CEAUL). Faculdade de Ciências. Universidade de Lisboa. https://orcid.org/0000-0002-8542-1706
João Malato Centro de Estatística e Aplicações (CEAUL). Faculdade de Ciências. Universidade de Lisboa. Lisboa; Instituto de Medicina Molecular João Lobo Antunes. Faculdade de Medicina. Universidade de Lisboa. Lisboa. https://orcid.org/0000-0003-4389-1483
João Carlos Winck Cardiovascular R&D Centre (UnIC). Faculdade de Medicina. Universidade do Porto. Porto; Unidade de Pneumologia. Instituto CUF Porto. Porto. https://orcid.org/0000-0002-2444-8710
António Vaz Carneiro Instituto de Saúde Baseada na Evidência (ISBE). Faculdade de Medicina. Universidade de Lisboa. Lisboa. https://orcid.org/0000-0002-2783-0544
Joan Serra Hoffman Aliança Millions Missing. Lisboa.
Jaime Branco Department of Rheumatology. Unidade Local de Saúde de Lisboa Ocidental. Lisboa; Comprehensive Health Research Centre (CHRC). NOVA Medical School. Universidade NOVA de Lisboa. Lisboa; NOVA Medical School. Universidade NOVA de Lisboa. Lisboa. https://orcid.org/0000-0001-7024-4375

DOI:

https://doi.org/10.20344/amp.21845

Keywords:

COVID-19/complications, Fatigue Syndrome, Chronic, Post-Acute COVID-19 Syndrome

Abstract

N/A

Downloads

Download data is not yet available.

References

Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133-46. DOI: https://doi.org/10.1038/s41579-022-00846-2

James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392:1789-858. DOI: https://doi.org/10.1016/S0140-6736(18)32279-7

Ferrari AJ, Santomauro DF, Aali A, Abate YH, Abbafati C, Abbastabar H, et al. Global incidence, prevalence, years lived with disability (YLDs), disabilityadjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403:2133-61. DOI: https://doi.org/10.1016/S0140-6736(24)00757-8

Rivera MC, Mastronardi C, Silva-Aldana CT, Arcos-Burgos M, Lidbury BA. Myalgic encephalomyelitis/chronic fatigue syndrome: a comprehensive review. Diagnostics. 2019;9:91. DOI: https://doi.org/10.3390/diagnostics9030091

Blomberg J, Gottfries CG, Elfaitouri A, Rizwan M, Rosén A. Infection elicited autoimmunity and myalgic encephalomyelitis/chronic fatigue syndrome: an explanatory model. Front Immunol. 2018;9:229. DOI: https://doi.org/10.3389/fimmu.2018.00229

Lim EJ, Ahn YC, Jang ES, Lee SW, Lee SH, Son CG. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). J Transl Med. 2020;18:100. DOI: https://doi.org/10.1186/s12967-020-02269-0

Instituto Nacional de Estatística. Estatísticas demográficas: 2022. Lisboa: INE; 2023. p. 19.

Pheby DF, Araja D, Berkis U, Brenna E, Cullinan J, de Korwin JD, et al. A literature review of GP knowledge and understanding of ME/CFS: a report from the socioeconomic working group of the European Network on ME/CFS (EUROMENE). Medicina. 2021;57:1-17. DOI: https://doi.org/10.3390/medicina57010007

Nacul L, Authier FJ, Scheibenbogen C, Lorusso L, Helland IB, Martin JA, et al. European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): expert consensus on the diagnosis, service provision, and care of people with ME/CFS in Europe. Medicina. 2021;57:510. DOI: https://doi.org/10.3390/medicina57050510

Űstűnkaya T, Machin R. Hidden from sight: why the complexity of ME/CFS needs to be recognised by policy makers. People, Place and Policy. 2021;15:91-9. DOI: https://doi.org/10.3351/ppp.2021.7537868743

Downloads

Published

2024-10-07

How to Cite

Sepúlveda N, Malato J, Winck JC, Vaz Carneiro A, Serra Hoffman J, Branco J. Post-Infection Fatigue Syndromes in the Era of Long COVID: The Case of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Acta Med Port [Internet]. 2024 Oct. 7 [cited 2024 Dec. 26];37(12):819-22. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/21845

Download Citation

Issue

Vol. 37 No. 12 (2024): December

Section

Perspective

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.